Biosimilars Cost Control And IP Protection
Source: Bioprocess Online
In addition to reflecting on a live poll of our audience, Kashiv Biosciences' Associate VP Kaushal Joshi discusses IP protection and cost control in biosimilars development and addresses audience questions on reference batches and assay development in this segment of the Bioprocess Online Live panel discussion Impact Of The Biosimilars Boom.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more